Cleared Traditional

K920145 - BIOPRO DRG CUSTOM HIP REPLACEMENT SYSTEM

K920145 is an FDA 510(k) clearance for BIOPRO DRG CUSTOM HIP REPLACEMENT SYSTEM, manufactured by Biopro, Inc.. The device is a Class 2 Orthopedic device with product code LZO cleared through the Traditional 510(k) pathway after a 276-day FDA review.

K920145 · Biopro, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1992
Decision
276d
Days
Class 2
Risk

K920145 is an FDA 510(k) clearance for the BIOPRO DRG CUSTOM HIP REPLACEMENT SYSTEM. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Biopro, Inc. (Port Huron, US). The FDA issued a Cleared decision on October 15, 1992 after a review of 276 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Biopro, Inc. devices

FDA 510(k) Submission Details - K920145

510(k) Number K920145 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 13, 1992
Decision Date October 15, 1992
Days to Decision 276 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 122d · This submission: 276d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 509
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K920145.
KINAMED 26MM BIOCERAN-Z TOTAL HIP FEMORAL BALL
K920219 · Kinamed, Inc. · Oct 1992
S-ROM ZIRCONIA CERMAMIC FEMORAL HEAD
K921111 · Joint Medical Products Corp. · Oct 1992
OSTEONICS ZIRCONIA C-TAPER FEMORAL BEARING HEAD
K915396 · Osteonics Corp. · Oct 1992
CERAMIC FEMORAL HEAD
K920593 · Dow Corning Wright · Aug 1992
FELDMUHLE CERAMIC HEAD
K920756 · Link America, Inc. · May 1992
HOWEDICA ZIRCONIA FEMORAL HEAD
K920577 · Howmedica Corp. · May 1992